(Q36507342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

The clinical relevance of low-density-lipoproteins size modulation by statins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Kaspar Berneis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Drugs and Therapy

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

205-217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-006-8283-X

Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-006-8283-X

Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-006-8283-X

Fluvastatin increases LDL particle size and reduces oxidative stress in patients with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-006-8283-X

Low-density lipoprotein size and cardiovascular risk assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-006-8283-X

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-006-8283-X

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-006-8283-X

10.1007/S10557-006-8283-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775666%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference